A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe

Ophthalmology, Macular Degeneration Clinical Trial

Official title:
Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe: A Follow-up Physician Survey

Status Completed

Clinical Trial Summary

With this follow up physician survey researcher want to collect the same data from all participants of the study using a highly structured questionnaire. The questionnaire will gather information related to physician characteristics and experience with Aflibercept, as well as assess physicians' knowledge and understanding of storage and preparation, proper injection technique, and the risks associated with Aflibercept injection into the eye (intravitreal injection). Analysis will be done using descriptive statistics.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Macular Degeneration
Ophthalmology, Macular Degeneration

Clinical Trial Details

NCT number	NCT04067583
Study type	Observational
Source	Bayer
Contact
Status	Completed
Phase
Start date	October 8, 2019
Completion date	April 23, 2020

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01447043` - Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)	N/A